Published in Obesity and Diabetes Week, December 22nd, 2003
According to recent research published in the journal Dialysis and Transplantation, "Extraneal, a new peritoneal dialysis solution, was recently approved by the U.S. Food and Drug Administration (FDA) for use during the long dwell of peritoneal dialysis (PD)."
"It represents a new class of osmotic agents with demonstrated clinical advantages over standard dextrose-based solutions, particularly for patients who would benefit from an improvement in ultrafiltration (UF)," said Richard J. Hamburger and Michael Alan Kraus at Indiana University. "Studies comparing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.